Showing results (781-790 of 1,140) with videos related to

Sort By:
Pageof 114
Environmental Technology|September 20, 2012
Chemical phosphorus removal: a clean strategy for piggery wastewater management in BrazilGabriela Wendler Fernandes, Airton Kunz, Ricardo Luís Radis Steinmetz, et al.
Journal of Professional Nursing : Official Journal of the American Association of Colleges of Nursing|December 21, 2019
Faculty Support for a Culture of Scholarship of Discovery: A Literature ReviewJennie L Van Schyndel, Sonja Koontz, Sara McPherson, et al.
Arthritis and Rheumatism|May 29, 2007
TNF polymorphisms in psoriasis: association of psoriatic arthritis with the promoter polymorphism TNF*-857 independent of the PSORS1 risk alleleKristian Reich, Ulrike Hüffmeier, Inke R König, et al.
The EMBO Journal|November 1, 1986
Subregions of a conserved part of the HIV gp41 transmembrane protein are differentially recognized by antibodies of infected individualsU Certa, W Bannwarth, D Stüber, et al.
Frontiers in Immunology|April 27, 2019
Immune Modulation to Enhance Bone Healing-A New Concept to Induce Bone Using Prostacyclin to Locally Modulate ImmunitySebastian Wendler, Claudia Schlundt, Christian H Bucher, et al.
European Review for Medical and Pharmacological Sciences|March 6, 2023
TIMP-1 as a biomarker in obstructive sleep apnea: screening, monitoring, risk stratification, and a step towards precision medicineM Traxdorf, J Haferkamp, M E Messbacher, et al.
IEEE Transactions on Medical Imaging|June 3, 2024
Multitask Weakly Supervised Generative Network for MR-US RegistrationMohammad Farid Azampour, Kristina Mach, Emad Fatemizadeh, et al.
Circulation|November 18, 2000
Complete arterial revascularization in multivessel coronary artery disease with 2 conduits (skeletonized grafts and T grafts)O Wendler, B Hennen, S Demertzis, et al.
Contemporary Clinical Trials|May 13, 2015
A prospective Phase 2a pilot study investigating focal percutaneous irreversible electroporation (IRE) ablation by NanoKnife in patients with localised renal cell carcinoma (RCC) with delayed interval tumour resection (IRENE trial)J J Wendler, M Porsch, S Nitschke, et al.
Chemmedchem|March 15, 2011
Sulfonylthiadiazoles with an unusual binding mode as partial dual peroxisome proliferator-activated receptor (PPAR) γ/δ agonists with high potency and in vivo efficacyStefanie Keil, Hans Matter, Karl Schönafinger, et al.
Pageof 114